BRCA1 and breast carcinoma: First, many more miRNAs were found to be differentially expressed between the carcinomas and asymptomatic normal breast tissue in BRCA1 and BRCA2 germ-line mutation carriers compared to the number of differentially expressed miRNAs between sporadic breast carcinomas and normal breast tissue as derived from the literature.